ArticleRespiration; international review of thoracic diseases2026
Endobronchial Valve Treatment Improves Regional Specific Ventilation in the Target Lung.
Article in Respiration; international review of thoracic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
<p>Introduction: Previous studies yielded inconsistent results regarding whether bronchoscopic lung volume reduction using endobronchial valves (EBVs) improves pulmonary ventilation. The aim of this study was to evaluate changes in ventilation following EBV treatment using a novel technique for assessing specific pulmonary ventilation: X-ray velocimetry (XV LVAS, 4DMedical, Los Angeles, CA, USA).
methodsPulmonary ventilation was assessed using XV pretreatment and 6 weeks after treatment. The main outcome was mean specific ventilation (MSV) (mL/mL) which is defined as the volume change in a lung region (from start to end of inspiration), divided by the volume of that region at the start of inspiration.
resultsNineteen patients were included (79% female, mean FEV
conclusionFor the first time, XV was utilized to measure specific pulmonary ventilation before and after EBV treatment. Our results demonstrate an overall increase in pulmonary ventilation across the whole lung, driven by an increase in the treated lung, despite a decrease in the non-treated lung. No association was observed between changes in pulmonary ventilation and changes in clinical outcomes. </p>.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.